Cite
HARVARD Citation
Schwartz, S. et al. (2019). Refining the selection of patients with metastatic colorectal cancer for treatment with temozolomide using proteomic analysis of O6-methylguanine-DNA-methyltransferase. European journal of cancer. pp. 164-174. [Online].